Announcement Published in a Journal Regarding Voluntary Disclosure of Phase II Study on the Safety, Tolerability and Preliminary Efficacy of Polyethylene Glycol Irinotecan as Second-Line Monotherapy for Small Cell Lung Cancer
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment